至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

CircRNA hsa_circ_0006220 acts as a tumor suppressor gene by regulating miR-197-5p/CDH19 in triple-negative breast cancer

Ann Transl Med. 2021-08; 
Yue Shi, Tao Han, Chong Liu
Products/Services Used Details Operation
Plasmid DNA Preparation … (chr17, 35800605–35800763) was synthesized and cloned into a vector (Genscript, Nanjing, China), named “ov-circ.” A mock vector with … or a negative control were synthesized and constructed into plasmid vectors (Genscript, Nanjing, China) that were named “sh-circ” and “sh-… Get A Quote

摘要

unassigned: Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancer (BC) subtypes. Circular ribonucleic acids (circRNAs) are a class of novel stable and conserved forms of ribonucleic acids (RNAs). circRNAs have been documented to be involved in multiple diseases, especially malignancies, through a competing endogenous RNA (ceRNA) mechanism. However, few studies have been conducted on the function of circRNAs in TNBC. Previously, hsa_circ_0006220 was found to be downregulated in BC tissues. The present study sought to explore the mechanism of hsa_circ_0006220 in TNBC progression. unassigned: A real-time polymerase chain reaction (PCR) was used to validate the expression of hsa_circ_0006... More

关键词

Triple-negative breast cancer (TNBC), circular RNA, hsa_circ_0006220, mechanism